Ratios	Dec 24	Dec 23	Dec 22	Dec 21
Liquidity Ratios
Current Ratio	―	2.67	1.30	1.23
Quick Ratio	―	2.67	1.30	1.23
Cash Ratio	―	1.95	1.06	0.88
Solvency Ratio	―	-0.88	-1.00	-1.07
Operating Cash Flow Ratio	―	-2.45	-1.31	0.00
Short-Term Operating Cash Flow Coverage	―	0.00	0.00	0.00
Net Current Asset Value	AU$ ―	AU$ -3.76M	AU$ -21.83M	AU$ -13.07M
Leverage Ratios
Debt-to-Assets Ratio	―	0.00	0.00	0.00
Debt-to-Equity Ratio	―	0.00	0.00	0.00
Debt-to-Capital Ratio	―	0.00	0.00	0.00
Long-Term Debt-to-Capital Ratio	―	0.00	0.00	0.00
Financial Leverage Ratio	―	1.93	2.56	1.69
Debt Service Coverage Ratio	―	-586.06	-68.72	-362.74
Interest Coverage Ratio	―	-584.59	-56.96	-400.83
Debt to Market Cap	―	0.00	0.00	0.00
Interest Debt Per Share	―	<0.01	0.50	0.00
Net Debt to EBITDA	―	0.76	0.42	0.38
Profitability Margins
Gross Profit Margin	―	1.08%	100.00%	100.00%
EBIT Margin	―	-1050.63%	-15777.22%	-11796.15%
EBITDA Margin	―	-1050.43%	-14732.44%	-10668.58%
Operating Profit Margin	―	-1050.63%	-12238.44%	-11803.33%
Pretax Profit Margin	―	-1052.43%	-15992.07%	-11825.59%
Net Profit Margin	―	-1055.27%	-16024.28%	-11838.59%
Continuous Operations Profit Margin	―	-1055.27%	-16024.28%	-11838.59%
Net Income Per EBT	―	100.27%	100.20%	100.11%
EBT Per EBIT	―	100.17%	130.67%	100.19%
Return on Assets (ROA)	―	-44.34%	-66.56%	-46.18%
Return on Equity (ROE)	―	-85.60%	-170.50%	-77.98%
Return on Capital Employed (ROCE)	―	-53.35%	-67.24%	-55.91%
Return on Invested Capital (ROIC)	―	-53.50%	-67.38%	-55.97%
Return on Tangible Assets	―	-96.08%	-208.94%	-210.94%
Earnings Yield	―	-78.40%	-140.32%	-
Efficiency Ratios
Receivables Turnover	―	0.35	0.30	0.07
Payables Turnover	―	0.57	0.00	0.00
Inventory Turnover	―	0.00	0.00	0.00
Fixed Asset Turnover	―	67.96	4.92	4.28
Asset Turnover	―	0.04	<0.01	<0.01
Working Capital Turnover Ratio	―	0.24	0.07	0.03
Cash Conversion Cycle	―	400.15	1.20K	5.58K
Days of Sales Outstanding	―	1.04K	1.20K	5.58K
Days of Inventory Outstanding	―	0.00	0.00	0.00
Days of Payables Outstanding	―	644.60	0.00	0.00
Operating Cycle	―	1.04K	1.20K	5.58K
Cash Flow Ratios
Operating Cash Flow Per Share	―	-5.28	-17.84	0.00
Free Cash Flow Per Share	―	-5.28	-17.84	0.00
CapEx Per Share	―	0.00	0.00	0.00
Free Cash Flow to Operating Cash Flow	―	1.00	1.00	0.00
Dividend Paid and CapEx Coverage Ratio	―	0.00	0.00	0.00
Capital Expenditure Coverage Ratio	―	0.00	0.00	0.00
Operating Cash Flow Coverage Ratio	―	0.00	0.00	0.00
Operating Cash Flow to Sales Ratio	―	-10.09	-76.78	0.00
Free Cash Flow Yield	―	-74.93%	-67.24%	0.00%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-1.28	-0.71	0.00
Price-to-Sales (P/S) Ratio	―	13.46	114.19	0.00
Price-to-Book (P/B) Ratio	―	1.09	1.22	0.00
Price-to-Free Cash Flow (P/FCF) Ratio	―	-1.33	-1.49	0.00
Price-to-Operating Cash Flow Ratio	―	-1.33	-1.49	0.00
Price-to-Earnings Growth (PEG) Ratio	―	0.01	-0.08	0.00
Price-to-Fair Value	―	1.09	1.22	0.00
Enterprise Value Multiple	―	-0.52	-0.35	0.38
Enterprise Value	―	19.79M	15.60M	-11.70M
EV to EBITDA	―	-0.52	-0.35	0.38
EV to Sales	―	5.45	52.12	-40.02
EV to Free Cash Flow	―	-0.54	-0.68	0.47
EV to Operating Cash Flow	―	-0.54	-0.68	0.00
Tangible Book Value Per Share	―	-0.53	-16.87	0.00
Shareholders’ Equity Per Share	―	6.46	21.83	0.00
Tax and Other Ratios
Effective Tax Rate	―	>-0.01	>-0.01	>-0.01
Revenue Per Share	―	0.52	0.23	0.00
Net Income Per Share	―	-5.53	-37.22	0.00
Tax Burden	―	1.00	1.00	1.00
Interest Burden	―	1.00	1.01	1.00
Research & Development to Revenue	―	7.57	58.68	47.20
SG&A to Revenue	―	4.55	50.86	44.54
Stock-Based Compensation to Revenue	―	0.00	0.00	0.00
Income Quality	―	0.00	0.48	0.00

Radiopharm Theranostics Limited Sponsored ADR (RADX) Ratios

Radiopharm Theranostics Limited Sponsored ADR Ratios